부산대학교 도서관

Lonial, Sagar ; Lee, Hans C ; Badros, Ashraf ; Trudel, Suzanne ; Nooka, Ajay K ; Chari, Ajai ; Abdallah, Al-Ola ; Callander, Natalie ; Lendvai, Nikoletta ; Sborov, Douglas ; Suvannasankha, Attaya ; Weisel, Katja ; Karlin, Lionel ; Libby, Edward ; Arnulf, Bertrand ; Facon, Thierry ; Hulin, Cyrille ; Kortüm, K Martin ; Rodríguez-Otero, Paula ; Usmani, Saad Z ; Hari, Parameswaran ; Baz, Rachid ; Quach, Hang ; Moreau, Philippe ; Voorhees, Peter M ; Gupta, Ira ; Hoos, Axel ; Zhi, Eric ; Baron, January ; Piontek, Trisha ; Lewis, Eric ; Jewell, Roxanne C ; Dettman, Elisha J ; Popat, Rakesh ; Esposti, Simona Degli ; Opalinska, Joanna ; Richardson, Paul ; Cohen, Adam D

In The Lancet Oncology February 2020 21(2):207-221

Bashir, Qaiser ; Thall, Peter F ; Milton, Denái R ; Fox, Patricia S ; Kawedia, Jitesh D ; Kebriaei, Partow ; Shah, Nina ; Patel, Krina ; Andersson, Borje S ; Nieto, Yago L ; Valdez, Ben C ; Parmar, Simrit ; Rondon, Gabriela ; Delgado, Ruby ; Hosing, Chitra ; Popat, Uday R ; Oran, Betul ; Ciurea, Stefan O ; Lin, Pei ; Weber, Donna M ; Thomas, Sheeba K ; Lee, Hans C ; Manasanch, Elisabet E ; Orlowski, Robert Z ; Williams, Loretta A ; Champlin, Richard E ; Qazilbash, Muzaffar H

In The Lancet Haematology May 2019 6(5):e266-e275

Manasanch, Elisabet E ; Shah, Jatin J ; Lee, Hans C ; Weber, Donna M ; Thomas, Sheeba K ; Amini, Behrang ; Feng, Lei ; Berkova, Zuzana ; Hildebrandt, Michelle ; Orlowski, Robert Z

In The Lancet Haematology December 2018 5(12):e628-e640

Haider AA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Division of Hematology/Oncology, University of Texas at Houston Health Science Center McGovern Medical School, Houston, TX, USA.; Marcoux C; Division of Hematology, Dalhousie University, Halifax, Nova Scotia, Canada.; Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tanner MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Smallbone P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Srour S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Saini N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ramdial J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tang G; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mohamedi AH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Siddiqui UR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Aljawai Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ye C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel KK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thomas SK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pasvolsky O; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Chohan KL; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gensini L; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Seif S; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sun X; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Becnel MR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gaballa MM; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee HC; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pasvolsky O; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel KK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ye JC; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Weber DM; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Orlowski RZ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thomas SK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sthomas@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Afrough A; Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. Aimaz.afrough@utsouthwestern.edu.; Dima D; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Razzo B; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Thomas Jefferson University, Philadelphia, PA, USA.; Goel U; Cleveland Clinic, Taussig Cancer Center, Lerner College of Medicine, Cleveland, OH, USA.; Sannareddy A; Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Pasvolsky O; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Vazquez-Martinez MA; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Ferreri CJ; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Banerjee R; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Khouri J; Cleveland Clinic, Taussig Cancer Center, Lerner College of Medicine, Cleveland, OH, USA.; Davis JA; The Medical University of South Carolina, Charleston, SC, USA.; Gaballa MR; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lieberman-Cribbin A; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Rana MS; Stanford University, Palo Alto, CA, USA.; Julian K; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Anwer F; Cleveland Clinic, Taussig Cancer Center, Lerner College of Medicine, Cleveland, OH, USA.; Shune L; University of Kansas, Kansas City, KS, USA.; DeJarnette S; University of Kansas, Kansas City, KS, USA.; Grajales-Cruz AF; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Ouchveridze E; University of Kansas, Kansas City, KS, USA.; De Avila G; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Susanibar-Adaniya SP; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Portuguese AJ; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Schrum D; Duke University, Durham, NC, USA.; Eberwein E; Duke University, Durham, NC, USA.; Hosoya H; Stanford University, Palo Alto, CA, USA.; Mikkilineni L; Stanford University, Palo Alto, CA, USA.; Kaur G; Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; McGuirk JP; University of Kansas, Kansas City, KS, USA.; Rossi A; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Herr MM; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Castaneda O; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Locke FL; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Raza S; Cleveland Clinic, Taussig Cancer Center, Lerner College of Medicine, Cleveland, OH, USA.; Lin Y; Mayo Clinic, Rochester, MN, USA.; Atrash S; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Sborov DW; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Voorhees PM; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Richard S; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Garfall AL; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Sidana S; Stanford University, Palo Alto, CA, USA.; Patel KK; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hansen DK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Cowan AJ; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Anderson LD Jr; Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. Larry.anderson@utsouthwestern.edu.; Lee HC; University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Dima D; Fred Hutch Cancer Center, University of Washington, Seattle, WA, USA. ddima@fredhutch.org.; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA. ddima@fredhutch.org.; Vazquez-Martinez MA; Moffitt Cancer Center, Tampa, FL, USA.; Davis JA; University of South Carolina, Charleston, SC, USA.; Goel U; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.; Afrough A; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Sannareddy A; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Pasvolsky O; MD Anderson Cancer Center, Houston, TX, USA.; Razzo B; University of Pennsylvania, Philadelphia, PA, USA.; Banerjee R; Fred Hutch Cancer Center, University of Washington, Seattle, WA, USA.; Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.; Grajales-Cruz A; Moffitt Cancer Center, Tampa, FL, USA.; Lieberman-Cribbin A; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Rana MS; Stanford University, Stanford, CA, USA.; Julian K; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; DeJarnette S; University of Kansas, Kansas City, KS, USA.; Portuguese AJ; Fred Hutch Cancer Center, University of Washington, Seattle, WA, USA.; Gaballa MR; MD Anderson Cancer Center, Houston, TX, USA.; De Avila G; Moffitt Cancer Center, Tampa, FL, USA.; Susaniba Adaniya S; University of Pennsylvania, Philadelphia, PA, USA.; Raza S; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.; Herr MM; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Ouchveridze E; University of Kansas, Kansas City, KS, USA.; Richards T; MD Anderson Cancer Center, Houston, TX, USA.; Hosoya H; Stanford University, Stanford, CA, USA.; Mikkilineni L; Stanford University, Stanford, CA, USA.; Kaur G; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Castaneda Puglianini O; Moffitt Cancer Center, Tampa, FL, USA.; Rossi A; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Lin Y; Mayo Clinic, Rochester, MN, USA.; Atrash S; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Sborov D; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Shain KH; Moffitt Cancer Center, Tampa, FL, USA.; Voorhees PM; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Richard S; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Garfall AL; University of Pennsylvania, Philadelphia, PA, USA.; Hansen DK; Moffitt Cancer Center, Tampa, FL, USA.; Sidana S; Stanford University, Stanford, CA, USA.; Patel KK; MD Anderson Cancer Center, Houston, TX, USA.; Cowan AJ; Fred Hutch Cancer Center, University of Washington, Seattle, WA, USA.; Anderson LD Jr; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Lee HC; MD Anderson Cancer Center, Houston, TX, USA.; Anwer F; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.; Ferreri CJ; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Shune L; University of Kansas, Kansas City, KS, USA.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Leleu, Xavier; Lee, Hans C; Zonder, Jeffrey A; Macro, Margaret; Ramasamy, Karthik; Hulin, Cyrille; Silar, Jiri; Kuhn, Matyas; Ren, Kaili; Bent-Ennakhil, Nawal; Cherepanov, Dasha; Stull, Dawn Marie; Terpos, Evangelos

Future Oncology; May2024, Vol. 20 Issue 14, p935-950, 16p

Rifkin, Robert M; Costello, Caitlin L; Birhiray, Ruemu E; Kambhampati, Suman; Richter, Joshua; Abonour, Rafat; Lee, Hans C; Stokes, Michael; Ren, Kaili; Stull, Dawn Marie; Cherepanov, Dasha; Bogard, Kimberly; Noga, Stephen J; Girnius, Saulius

Future Oncology; Jan2024, Vol. 20 Issue 3, p131-143, 12p

Dillard CM; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Gurumurthi A; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lee HC; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Thomas SK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Weber DM; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Orlowski RZ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Patel KK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: kpatel1@mdanderson.org.; Hildebrandt MAT; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: mhildebr@mdanderson.org.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Lee HC; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Becnel MR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.; Pasvolsky O; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Murga A; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Johnson RJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Thomas SK; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Steiner R; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Iyer SP; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Weber DM; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Patel KK; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Kaufman GP; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Manasanch EE; GlaxoSmithKline, Philadelphia, Pennsylvania, USA.; Orlowski RZ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Lee HC; The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: Hans.Lee@scri.com.; Zonder JA; Karmanos Cancer Institute, Detroit, MI.; Dhodapkar MV; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.; Jagannath S; Icahn School of Medicine at Mount Sinai, New York, NY.; Hoffman JE; Department of Medicine, University of Miami Health System, Miami, FL.; Suvannasankha A; Department of Medicine, Indiana University Simon Cancer Center and Richard L. Roudebush VAMC, Indianapolis, IN.; Shah MR; Department of Medicine, Rutgers Cancer Institute, New Brunswick, NJ.; Lentzsch S; Columbia University Irving Medical Center, New York, NY.; Baz R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.; Maly JJ; Norton Cancer Institute, Louisville, KY.; Namburi S; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA.; Pianko MJ; Department of Internal Medicine, Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI.; Ye JC; The University of Texas MD Anderson Cancer Center, Houston, TX.; Wu KL; Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium.; Silbermann R; Department of Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Min CK; Department of Hematology, College of Medicine, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.; Vekemans MC; Hematology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.; Munder M; Department of Internal Medicine III, Universitätsmedizin Mainz, Mainz, Germany.; Byun JM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.; Martínez-Lopez J; Hospital Universitario 12 de Octubre, i+12, School of Medicine Universidad Complutense, CNIO, Madrid, Spain.; DeVeaux M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Roccia T; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Chokshi D; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Seraphin M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Knorr K; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Boyapati A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Hazra A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Rodriguez Lorenc K; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Kroog GS; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Bumma N; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Richter J; Icahn School of Medicine at Mount Sinai, New York, NY.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Cavo M; Department of Medical and Surgical Sciences, University of Bologna, Bologna. michele.cavo@unibo.it.; Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo.; Dimopoulos M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece; Department of Medicine, Korea University, Seoul.; Delforge M; Department of Hematology, Catholic University of Leuven, Leuven.; Escalante F; Hematology Department, University Hospital of Leon, IBIOLEON, Leon.; Kleinman D; Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY.; Lee HC; MD Anderson Cancer Center, Houston, Texas.; Vij R; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO.; Greil R; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials, Paracelsus Medical University Salzburg, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg.; Melchardt T; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials, Paracelsus Medical University Salzburg, Salzburg.; Antonioli E; Hematology Department, Careggi Hospital, Florence.; Lysen A; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo.; Camadoo-O'Byrne L; GSK, Stevenage.; Bitetti J; GSK, Zug.; D'Estrube T; GSK, London.; Fry M; GSK, Stevenage.; Byrne J; GSK, Upper Providence, PA.; Vossen CY; Syneos Health, Amsterdam.; Sapra S; GSK, Upper Providence, PA.; Benson VS; GSK, London.; Mouro J; GSK, Neuchatel.; Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY.

Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Puig N; University Hospital of Salamanca, Salamanca, Spain.; Leleu X; CHU Poitiers, Poitiers, France.; Lee HC; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Davies FE; NYU Langone, New York, New York, USA.; Hájek R; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Hungria V; Clinica Sao Germano, Sao Paulo, Brazil.; Thompson MA; Tempus AI, Chicago, Illinois, USA.; Cook G; University of Leeds, Leeds, UK.; Ojeda JV; Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Mexico City, Mexico.; Weisel KC; Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany.; Berdeja JG; Tennessee Oncology, Nashville, Tennessee, USA.; Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Symeonidis A; University of Patras Medical School & Olympion Hospital, Patras, Greece.; Nascimento-Ferreira I; Takeda Pharmaceuticals International AG, Opfikon, Switzerland.; Arthur D; Takeda Development Center Americas, Inc. (TDCA), Cambridge, Massachusetts, USA.; Mokrá L; Institut biostatistiky a analýz, s.r.o., Brno, Czech Republic.; Ren K; Takeda Development Center Americas, Inc. (TDCA), Cambridge, Massachusetts, USA.; Cherepanov D; Takeda Development Center Americas, Inc. (TDCA), Cambridge, Massachusetts, USA.; Terpos E; National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

Kumar SK; 1Mayo Clinic Comprehensive Cancer Center.; Callander NS; 2University of Wisconsin Carbone Cancer Center.; Adekola K; 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University.; Anderson LD Jr; 4UT Southwestern Simmons Comprehensive Cancer Center.; Baljevic M; 5Vanderbilt-Ingram Cancer Center.; Baz R; 6Moffitt Cancer Center.; Campagnaro E; 7University of Michigan Rogel Cancer Center.; Costello C; 8UC San Diego Moores Cancer Center.; D'Angelo C; 9Fred & Pamela Buffett Cancer Center.; Derman B; 10The UChicago Medicine Comprehensive Cancer Center.; Devarakonda S; 11The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.; Elsedawy N; 12St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.; Godara A; 13Huntsman Cancer Institute at the University of Utah.; Godby K; 14O'Neal Comprehensive Cancer Center at UAB.; Hillengass J; 15Roswell Park Comprehensive Cancer Center.; Holmberg L; 16Fred Hutchinson Cancer Center.; Htut M; 17City of Hope National Medical Center.; Huff CA; 18Johns Hopkins Kimmel Cancer Center.; Hultcrantz M; 19Memorial Sloan Kettering Cancer Center.; Kang Y; 20Duke Cancer Institute.; Larson S; 21UCLA Jonsson Comprehensive Cancer Center.; Lee HC; 22The University of Texas MD Anderson Cancer Center.; Liedtke M; 23Stanford Cancer Institute.; Martin T; 24UCSF Helen Diller Family Comprehensive Cancer Center.; Omel J; 25Patient Advocate.; Robinson TJ; 26Yale Cancer Center/Smilow Cancer Hospital.; Rosenberg A; 27UC Davis Comprehensive Cancer Center.; Sarosiek SR; 28Dana-Farber/Brigham and Women's Cancer Center.; Schroeder MA; 29Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.; Sherbenou D; 30University of Colorado Cancer Center.; Suvannasankha A; 31Indiana University Melvin and Bren Simon Comprehensive Cancer Center.; Valent J; 32Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.; Varshavsky-Yanovsky AN; 33Fox Chase Cancer Center.; Vogl D; 34Abramson Cancer Center at the University of Pennsylvania.; Ye JC; 22The University of Texas MD Anderson Cancer Center.; Kovach E; 35National Comprehensive Cancer Network.; Kumar R; 35National Comprehensive Cancer Network.

Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

Banerjee R; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Kaur G; Mount Sinai School of Medicine, New York, New York, USA.; Razzo BM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Jefferson University, Philadelphia, Pennsylvania, USA.; Portuguese AJ; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Sidana S; Stanford University, Palo Alto, California, USA.; Richards T; MD Anderson Cancer Center, Houston, Texas, USA.; Grajales-Cruz A; Moffitt Cancer Center, Tampa, Florida, USA.; Richard S; Mount Sinai School of Medicine, New York, New York, USA.; Shune L; University of Kansas Medical Center, Kansas City, Kansas, USA.; Khouri J; Cleveland Clinic, Cleveland, Ohio, USA.; Dima D; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Lee HC; MD Anderson Cancer Center, Houston, Texas, USA.; Patel KK; MD Anderson Cancer Center, Houston, Texas, USA.; Pasvolsky O; MD Anderson Cancer Center, Houston, Texas, USA.; Vazquez-Martinez M; Moffitt Cancer Center, Tampa, Florida, USA.; Hansen DK; Moffitt Cancer Center, Tampa, Florida, USA.; Afrough A; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.; Davis JA; Medical University of South Carolina, Charleston, South Carolina, USA.; Hashmi H; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Atrash S; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, USA.; Ferreri CJ; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, USA.; Julian KL; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Herr MM; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Midha S; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Costello P; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Forsberg P; Colorado Blood Cancer Institute, Denver, Colorado, USA.; de Menezes Silva Corraes A; Mayo Clinic, Rochester, Minnesota, USA.; Lin Y; Mayo Clinic, Rochester, Minnesota, USA.; Cowan AJ; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Anderson LD Jr; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.; Garfall AL; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE; In Process

Pasvolsky O; MD Anderson Cancer Center, Houston, TX, USA. opasvolsky@mdanderson.org.; Dima D; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Feng L; MD Anderson Cancer Center, Houston, TX, USA.; Dong W; MD Anderson Cancer Center, Houston, TX, USA.; Richards T; MD Anderson Cancer Center, Houston, TX, USA.; Davis JA; Medical University of South Carolina, Charleston, SC, USA.; Afrough A; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Vazquez-Martinez M; Moffitt Cancer Center, Tampa, FL, USA.; Sannareddy A; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Goel U; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Banerjee R; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Khouri J; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Cervoni F; MD Anderson Cancer Center, Houston, TX, USA.; Gaballa MR; MD Anderson Cancer Center, Houston, TX, USA.; Lieberman-Cribbin A; Mount Sinai School of Medicine, New York, NY, USA.; Rana MS; Stanford University, Palo Alto, CA, USA.; Julian K; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Ferreri CJ; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Shune L; University of Kansas Medical Center, Kansas City, KS, USA.; DeJarnette S; University of Kansas Medical Center, Kansas City, KS, USA.; Bhurtel E; University of Kansas Medical Center, Kansas City, KS, USA.; Susanibar Adaniya S; Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Portuguese A; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hosoya H; Stanford University, Palo Alto, CA, USA.; Mikkilineni L; Stanford University, Palo Alto, CA, USA.; Kaur G; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Rossi A; Mount Sinai School of Medicine, New York, NY, USA.; Herr MM; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Schrum D; Duke University Cancer Institute, Durham, NC, USA.; Lin C; Duke University Cancer Institute, Durham, NC, USA.; Raza S; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Midha S; Dana-Farber Cancer Institute, Boston, MA, USA.; Omar N; Dana-Farber Cancer Institute, Boston, MA, USA.; Atarsh S; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; McGuirk J; University of Kansas Medical Center, Kansas City, KS, USA.; Sborov D; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Voorhees P; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Anwer F; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Alsina M; Moffitt Cancer Center, Tampa, FL, USA.; Freeman C; Moffitt Cancer Center, Tampa, FL, USA.; Garfall AL; Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Razzo BM; Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Sidana S; Stanford University, Palo Alto, CA, USA.; Cowan AJ; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Anderson LD Jr; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Hansen DK; Moffitt Cancer Center, Tampa, FL, USA.; Richard S; Mount Sinai School of Medicine, New York, NY, USA.; Patel KK; MD Anderson Cancer Center, Houston, TX, USA.; Lee HC; MD Anderson Cancer Center, Houston, TX, USA. hclee@mdanderson.org.; Grajales-Cruz A; Moffitt Cancer Center, Tampa, FL, USA.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Marcoux C; Division of Hematology, Dalhousie University, Halifax, Nova Scotia, Canada.; Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tanner MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Srour S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Saini N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lin P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Saeed A; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Haider AA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Hematology/Oncology, McGovern Medical School, The University of Texas, Health Sciences Center at Houston, Houston, Texas.; Ramdial J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Irfan S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; YagoNieto; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Aljawai Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Patel KK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Thomas SK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Pasvolsky O; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: opasvolsky@mdanderson.org.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Pasvolsky O; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Marcoux C; Division of Hematology, Dalhousie University, Halifax, Canada.; Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Haider AA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tanner MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Srour S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Saini N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Smallbone P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ramdial J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mohamedi AH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Siddiqui UR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jamil A; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Aljawai Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel KK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thomas SK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mqazilba@mdanderson.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: hans.lee@scri.com.; Bumma N; Division of Hematology/Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Richter J; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.; Zonder JA; Department of Hematology and Oncology, Karmanos Cancer Institute, Detroit, MI.; Hoffman JE; Department of Medicine, Division of Hematology/Oncology, University of Miami Health System, Miami, FL.; Zhou ZY; Analysis Group, Inc., Boston, MA.; García-Horton V; Analysis Group, Inc., Boston, MA.; Fillbrunn M; Analysis Group, Inc., Boston, MA.; Wang H; Analysis Group, Inc., Boston, MA.; Mattera M; Analysis Group, Inc., Boston, MA.; Ma W; Analysis Group, Inc., Boston, MA.; Inocencio TJ; Department of Oncology, Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Xu Y; Department of Oncology, Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Bergrath E; Department of Oncology, Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Harnett J; Department of Oncology, Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Roccia T; Department of Oncology, Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Knorr K; Department of Oncology, Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Kroog GS; Department of Oncology, Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Lorenc KR; Department of Oncology, Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Ma Q; Department of Oncology, Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Jagannath S; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE